Alpha 2.0
Login Register
» Authors » Vinod Arora

Vinod Arora

Explore the profile of Vinod Arora including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 52
Citations 705
Followers 0
Related Specialties
Gastroenterology
Pharmacology
Chemistry
Top 10 Co-Authors
Rakhi Maiwall
Shiv Kumar Sarin
Guresh Kumar
Ankur Jindal
Rajan Vijayaraghavan
Shiv K Sarin
Saggere Muralikrishna Shasthry
Priyanka Jain
Akash Shukla
Manoj Kumar
Published In
Hepatol Int
Hepatology
J Clin Exp Hepatol
Am J Gastroenterol
Dig Dis Sci
Affiliations
Soon will be listed here.
Recent Articles
1.
Acute-on-chronic liver failure (ACLF): the 'Kyoto Consensus'-steps from Asia
Choudhury A, Kulkarni A, Arora V, Soin A, Dokmeci A, Chowdhury A, et al.
Hepatol Int . 2025 Feb; 19(1):1-69. PMID: 39961976
Acute-on-chronic liver failure (ACLF) is a condition associated with high mortality in the absence of liver transplantation. There have been various definitions proposed worldwide. The first consensus report of the...
2.
Safety and Effectiveness of Naltrexone in the Management of Alcohol Use Disorder in Patients With Alcohol-associated Cirrhosis: First Clinical Observation From Indian Cohort
Varshney M, Kaur A, Sarin S, Shasthry S, Arora V
J Clin Exp Hepatol . 2024 Dec; 15(2):102447. PMID: 39640196
Background And Aims: Naltrexone is a promising drug to treat alcohol use disorder with limited evidence of safety in liver diseases. An observational study was performed to study the safety,...
3.
Determining the Target Concentration of Propofol for Sedation in Patients Undergoing Endoscopic Retrograde Cholangiopancreatography: A Target-Controlled Infusion Approach
S S, Dhingra U, Sindwani G, Yadav A, Arora V, Tempe D
Cureus . 2024 Jul; 16(6):e62936. PMID: 39050328
Introduction Endoscopic retrograde cholangiopancreatography (ERCP) is vital for diagnosing and treating biliary and pancreatic diseases, necessitating deep sedation typically achieved through total intravenous anesthesia. Propofol, with its favorable pharmacokinetic profile,...
4.
Impact of Diabetes, Drug-Induced Liver Injury, and Sepsis on Outcomes in Metabolic Dysfunction Associated Fatty Liver Disease-Related Acute-on-Chronic Liver Failure
Kumar A, Arora A, Choudhury A, Arora V, Rela M, Jothimani D, et al.
Am J Gastroenterol . 2024 Jul; PMID: 39016385
Introduction: The prevalence of metabolic dysfunction-associated fatty liver disease (MAFLD) and its complication, MAFLD-related acute-on-chronic liver failure (MAFLD-ACLF), is rising. Yet, factors determining patient outcomes in MAFLD-ACLF remain understudied. Methods:...
5.
Midodrine plus propranolol versus propranolol alone in preventing first bleed in patients with cirrhosis and severe ascites: a randomized controlled trial
Ranjan A, Jindal A, Maiwall R, Vashishtha C, Vijayaraghavan R, Arora V, et al.
Hepatol Int . 2024 May; 18(4):1261-1270. PMID: 38727780
Background: Propranolol, a non-selective beta-blocker, commonly used to prevent variceal bleed, but might precipitate circulatory dysfunction in severe ascites. Midodrine, an alpha-1 adrenergic agonist improves renal perfusion and systemic hemodynamics....
6.
Early Versus Standard Initiation of Terlipressin for Acute Kidney Injury in ACLF: A Randomized Controlled Trial (eTerli Study)
Jindal A, Singh H, Kumar G, Arora V, Sharma M, Maiwall R, et al.
Dig Dis Sci . 2024 Apr; 69(6):2204-2214. PMID: 38637454
Background And Aims: Terlipressin infusion is effective in hepatorenal syndrome (HRS-AKI). However, its efficacy for HRS-AKI resolution in acute-on-chronic liver failure (ACLF) patients has been suboptimal. Progression of AKI is...
7.
Dynamic analysis of acute deterioration in chronic liver disease patients using modified quick sequential organ failure assessment
Song D, Kim H, Jung Y, Kim T, Yim H, Yoon E, et al.
Clin Mol Hepatol . 2024 Apr; 30(3):388-405. PMID: 38600873
Background/aims: Quick sequential organ failure assessment (qSOFA) is believed to identify patients at risk of poor outcomes in those with suspected infection. We aimed to evaluate the ability of modified...
8.
APASL clinical practice guidelines on the management of acute kidney injury in acute-on-chronic liver failure
Maiwall R, Singh S, Angeli P, Moreau R, Krag A, Singh V, et al.
Hepatol Int . 2024 Apr; 18(3):833-869. PMID: 38578541
Acute-on-chronic liver failure (ACLF) is a syndrome that is characterized by the rapid development of organ failures predisposing these patients to a high risk of short-term early death. The main...
9.
Tranexamic acid in upper gastrointestinal bleed in patients with cirrhosis: A randomized controlled trial
Kumar M, Venishetty S, Jindal A, Bihari C, Maiwall R, Vijayaraghavan R, et al.
Hepatology . 2024 Mar; 80(2):376-388. PMID: 38441903
Background And Aims: Patients with Child-Turcotte-Pugh class B and C cirrhosis with upper gastrointestinal bleeding (UGIB) have systemic as well as localized (in the mucosa of the esophagus and stomach)...
10.
Long Term HBsAg Responses to Peg-Interferon Alpha-2b in HBeAg Negative Chronic Hepatitis B Patients Developing Clinical Relapse after Stopping Long-Term Nucleos(t)ide Analogue Therapy
Kumar K, Jindal A, Gupta E, Trehanpati N, Shasthry S, Maiwall R, et al.
J Clin Exp Hepatol . 2023 Dec; 14(1):101272. PMID: 38076362
Background And Aims: A high proportion of hepatitis B e antigen (HBeAg)-negative chronic hepatitis B (CHB) patients develop clinical relapse after stopping long-term nucleotide analogues (NAs). The aim of this...